Approval · Notice of Compliance 27407 · 2022
NAPROSYN: Notice of Compliance 27407
Issued January 11, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27407
- Date
- January 11, 2022
- Company
- Atnahs Pharma Uk LimitedBasildon, Essex, United Kingdom
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Safety updates to Product Monograph as per Advisement Letter
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NAPROSYN | Not yet assigned | — |